Catalog

Solution for infusion.
Analgesic non-narcotic drug.

Paracetamol has analgesic, antipyretic and mild anti-inflammatory effects.

Solution for intravenous administration.

1 ml of Hemastad-Rn solution contains:
active substance: tranexamic acid - 50 mg
excipients: water for injection - up to 1 ml.

Injection.

Means for the treatment of liver diseases.
1 ml of solution contains:
active substance: L-ornithine L-aspartate - 100 mg;
and excipients.

Composition:
1 bottle contains:
active substance: thiamine hydrochloride - 100.0 mg, pyridoxine hydrochloride - 100.0 mg, cyanocobalamin –1.0 mg, lidocaine hydrochloride - 20.0 mg;
excipients: benzyl alcohol - 40.0 mg, sodium polyphosphate - 20.0 mg, potassium ferricyanide - 0.2 mg, sodium hydroxide - up to pH 4.0-5.0, water for injection - up to 2 ml.

Composition:
1 bottle contains:
active substance: thioctic acid - 600 mg;
excipients: trometamol, water for injection - up to 24 ml.

Medical device
Nasal spray.

Hygienic care for the nasal cavity of infants, children and adults.

Composition:
1 ml of solution contains:
active substance: xylometazoline hydrochloride 0.50 mg or 1.00 mg;
excipients: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, disodium edetate, benzalkonium chloride, sorbitol, sodium chloride, hypromellose, purified water.

Composition:
1 ml of nasal spray contains:
active substance: xylometazoline hydrochloride 1.00 or 0.50 mg;
excipients: sodium dihydrogen phosphate, disodium phosphate dihydrate, disodium edetate, benzolconium chloride, sorbitol, sodium chloride, hypromellose, purified water.

Composition:
1 ml of nasal spray contains:
active substance: xylometazoline hydrochloride 1.00 or 0.50 mg;
excipients: sodium dihydrogen phosphate, disodium phosphate dihydrate, disodium edetate, benzolconium chloride, sorbitol, sodium chloride, hypromellose, purified water.

Composition:
1 ml of solution contains:
active substance: naphazoline nitrate-1.00 mg;
excipients: boric acid, disodium edetate, sodium chloride, benzalkonium chloride, sodium hydroxide, purified water.

Composition:
1 ml of solution contains:
active substance: naphazoline nitrate-1.00 mg;
excipients: boric acid, disodium edetate, sodium chloride, benzalkonium chloride, eucalyptus oil, macrogolglycerol hydroxystearate, sodium hydroxide, purified water.

Composition:
1 ml of solution contains:
active substances: phenylephrine (in the form of phenylephrine hydrochloride) - 2.50 mg, dimethindene maleate - 0.25 mg.
excipients: benzalkonium chloride, anhydrous citric acid, disodium phosphate dihydrate, sorbitol, lavender oil, purified water.

Composition:
1 ml of solution contains:
active substance: oxymetazoline hydrochloride - 0.50 mg;
excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

Composition:
1 ml of solution contains:
active substance: oxymetazoline hydrochloride - 0.50 mg;
excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, menthol, macrogolglycerol hydroxystearate, purified water.

Composition:
1 ml of solution contains:
active substance: oxymetazoline hydrochloride 0.10 mg, or 0.25 mg, or 0.50 mg; excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

Composition:
1 ml of solution contains:
active substance: oxymetazoline hydrochloride 0.10 mg, or 0.25 mg, or 0.50 mg; excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

Composition:
1 ml of solution contains:
active substance: oxymetazoline hydrochloride 0.10 mg, or 0.25 mg, or 0.50 mg; excipients: glycerin, citric acid monohydrate, sodium citrate, benzalkonium chloride, purified water.

Composition:
1 ml drops for oral administration contains:
active substance: 1 mg dimethindene maleate;
excipients: disodium phosphate dihydrate, citric acid monohydrate, benzoic acid, disodium edetate, sodium saccharin, propylene glycol, purified water.

Magnesol contains magnesium and is used to correct deficiency of this element in the body. The combination of several symptoms may indicate  deficiency of magnesium in the body.

Nasal drops.

1 ml of the solution contains: phenylephrine 2.5 mg, dimethindene maleate 0.25 mg.
Combination drug of vasoconstrictive and antiallergic ingredients.

Ear drops

Contains: phenazone 40 mg, lidocaine hydrochloride 10 mg.
Anti-inflammatory and analgesic agent.

Lyophilizate for the preparation of nasal drops.

Contains: interferon human recombinant alpha-2b 1mln IU.
Antiviral agent for intranasal and inhalation use.

The composition of the drug:
1 suppository Ruferon-Rn 150,000 IU contains:
active component: interferon human recombinant alpha-2b with an activity of 150,000 IU; excipients: ascorbic acid, glycerol monostearate, solid fat.
1 suppository Ruferon-Rn 250,000 IU contains:
active component: interferon human recombinant alpha-2b with an activity of 250,000 IU, excipients: ascorbic acid, glycerol monostearate, solid fat.

The composition of the drug:
1 suppository Ruferon-Rn 500000 IU contains:
active substance: interferon human recombinant alpha-2b activity of 500,000 IU
excipients: ascorbic acid, glycerol monostearate, solid fat.
1 suppository Ruferon-Rn 1,000,000 IU contains:
active substance: interferon human recombinant alpha-2b activity of 1,000,000 IU
excipients: ascorbic acid, glycerol monostearate, solid fat.

The composition of the drug:
1 suppository Ruferon-Rn 150,000 IU contains:
active component: interferon human recombinant alpha-2b with an activity of 150,000 IU; excipients: ascorbic acid, glycerol monostearate, solid fat.
1 suppository Ruferon-Rn 250,000 IU contains:
active component: interferon human recombinant alpha-2b with an activity of 250,000 IU, excipients: ascorbic acid, glycerol monostearate, solid fat.

The composition of the drug:
1 suppository Ruferon-Rn 500000 IU contains:
active substance: interferon human recombinant alpha-2b activity of 500,000 IU
excipients: ascorbic acid, glycerol monostearate, solid fat.
1 suppository Ruferon-Rn 1,000,000 IU contains:
active substance: interferon human recombinant alpha-2b activity of 1,000,000 IU
excipients: ascorbic acid, glycerol monostearate, solid fat.

Vaginal suppositories

Contains: Sertaconazole Nitrate 300 mg.
Antifungal agent for the topical use in gynenology.

Vaginal suppositories

Contains: metronidazole 100 mg, miconazole nitrate 100 mg.
Combination drug with antimicrobial, antiprotozoal and antifungal action for use in gynecology.

Vaginal suppositories

Contains: metronidazole 500 mg, miconazole nitrate 100 mg.
Combination drug with antimicrobial, antiprotozoal and antifungal action for use in gynecology.

Vaginal suppositories

Contains: povidone-iodine 200 mg.
Antiseptic agent for the treatment of gynecological diseases.

Vaginal suppositories

Contains: dexpanthenol 100 mg, chlorhexidine bigluconate 16 mg.
Combination drug for topical use in gynecology, has a regenerative, antiseptic and metabolic action.

Vaginal suppositories

Contains: natamycin 100 mg.
Topical antifungal agent for use in gynecology.

Vaginal suppositories

Contains: miconazole nitrate 100 mg
Antifungal drug for use in gynecology.

Vaginal suppositories

Contains: lactobacillus acidophilus 107 CFU
Probiotic agent of the topical use in gynecology.

Rectal suppositories

Contains: bisacodyl 10 mg.
Laxative.

Rectal suppositories

Contains: ibuprofen 60 mg.
Non-steroidal anti-inflammatory drug.

Vaginal suppositories

Contains: chlorhexidine digluconate 16 mg.
Antiseptic medicinal product for topical use in gynecology.

Composition:
1 tablet Moxodine 0.2 mg contains:
active substance: moxonidine - 0.2 mg
excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.
1 tablet Moxodine 0.4 mg contains:
active substance: moxonidine - 0.4 mg
excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.

Composition:
1 tablet Moxodine 0.2 mg contains:
active substance: moxonidine - 0.2 mg
excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.
1 tablet Moxodine 0.4 mg contains:
active substance: moxonidine - 0.4 mg
excipients: microcrystalline cellulose, povidone K 30, sodium starch glycolate (type A), magnesium stearate, lactose monohydrate, shell: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc.

Tablets

Composition per tablet:
active substance: valganciclovir - 450 mg (as valganciclovir hydrochloride - 496.3 mg);
excipients: microcrystalline cellulose, crospovidone, povidone K30, magnesium stearate; shell (polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc).

Tablets

1 tablet of 250 mg contains:
active substance: tranexamic acid - 250 mg;
and excipients.

Tablets

1 tablet of 500 mg contains:
active substance: tranexamic acid - 500 mg;
and excipients.

Composition per tablet:
active substance: ibuprofen 200 mg;
excipients: microcrystalline cellulose, anhydrous colloidal silicon dioxide, magnesium stearate, corn starch, shell (polyvinyl alcohol, macrogol, talc, titanium dioxide).

Composition per tablet:
active substance: diosmin 600 mg;
excipients: microcrystalline cellulose, croscarmellose sodium, hypromellose, magnesium stearate.

Sonex Tablets

Contains: Zopiclone 7.5 mg.
Sleeping and sedative drug
Used to treat severe sleep disorders: situational and / or temporary insomnia.

Lozenges

Contains: dry extract of Salvia L. leaves 12.5 mg
Agent with a topical anti-inflammatory effect.

Tablets

Contains: nifuroxazide 100 mg
Antimicrobial agent for the treatment of intestinal infections.

Dispersible tablets

Contains: smectite dioctahedral 750 mg.
Antidiarrhoeal drug, sorbent.

Tablets

Contains: Ornidazole 500 mg.
Antiprotozoal agent.

Tablets

Contains: nimesulide 100 mg.
Non-steroidal anti-inflammatory drug.

Tablets

Contains: melatonin 3 mg.
Sleeping and sedative agent.

Tablets

Contains: magnesium lactate dihydrate 334 mg, equivalent to 34 mg of magnesium, pyridoxine hydrochloride 5 mg.
Combination drug of magnesium and vitamin B6.

Lozenges.

Contains: cetylpyridinium chloride 1.5 mg
Topical antiseptic for the mouth and throat.

Tablets

Contains: ibuprofen 400 mg.
Non-steroidal anti-inflammatory drug.

Coated tablets

Contains: dry extract of the Silybum marianum fruits, equivalent to 35 mg of silymarin.
Hepatoprotector of plant origin.

Tablets

Contains: diosmin 450 mg.
Venotonic and angioprotective agent.

Lozenges

Contains: chlorhexidine 2 mg, tetracaine 0.2 mg, ascorbic acid 50 mg.
Local antiseptic medicinal product with an analgesic effect.